Pasar al contenido principal

CONTRIBUCION DE LA CARGA DE VARIANTES RARAS EN LOS TRASTORNOS PSIQUIATRICOS EN UNA POBLACION INFANTO-ADOLESCENTE CON FUNCIONAMIENTO INTELECTUAL LIMITE/DISCAPACIDAD INTELECTUAL LEVE

PI19/01902

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARC TAULI
Centro realización CORPORACION SANITARIA PARC TAULI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Further delineation of the SCAF4-associated neurodevelopmental disorder

  • Schmid, C.M.
  • Gregor, A.
  • Ruiz, Anna|||0000-0001-7314-5962
  • Manso Bazús, C.
  • Herman, I.
  • Ammouri, F.
  • Kotzaeridou, U.
  • McNiven, V.
  • Dupuis, L.|||0000-0002-6068-8199
  • Steindl, K.
  • Begemann, A.|||0000-0001-6762-0819
  • Rauch, Anita|||0000-0003-2930-3163
  • Suter, A.A.
  • Isidor, B.
  • Mercier, S.
  • Nizon, M.|||0000-0003-2170-4210
  • Cogné, B.|||0000-0002-5503-6292
  • Deb, W.|||0000-0002-5103-8573
  • Besnard, T.
  • Haack, Tobias B.|||0000-0001-6033-4836
  • Falb, R.J.
  • Müller, A.J.
  • Linden, T.
  • Haldeman-Englert, C.R.
  • Ockeloen, C.W.|||0000-0003-0329-1520
  • Mattioli, F.|||0000-0002-1595-4320
  • Reymond, A.|||0000-0003-1030-8327
  • Ibrahim, N.
  • Naz, S.
  • Lacaze, E.
  • Bassetti, J.A.
  • Hoefele, Julia|||0000-0002-7917-7129
  • Brunet, Theresa|||0000-0002-5183-780X
  • Riedhammer, K.M.
  • Elloumi, Houda Z.
  • Person, Richard
  • Zou, Fanggeng
  • Kahle, Juliette J.
  • Cremer, Kirsten
  • Schmidt, Axel|||0000-0002-9780-7243
  • Delrue, Marie-Ange
  • Almeida, Pedro M.
  • Ramos, Fabiana
  • Srivastava, Siddharth|||0000-0001-7008-1879
  • Quinlan, Aisling
  • Robertson, Stephen|||0000-0002-5181-7809
  • Manka, Eva
  • Kuechler, Alma
  • Spranger, Stephanie
  • Nowaczyk, Malgorzata J. M.
  • Elshafie, Reem M.
  • Alsharhan, Hind
  • Hillman, Paul R.
  • Dunnington, Leslie A.
  • Braakman, Hilde M. H.|||0000-0001-8053-5918
  • McKee, Shane
  • Moresco, Angelica|||0000-0002-8827-6196
  • Ignat, Andrea-Diana
  • Newbury-Ecob, Ruth
  • Banneau, Guillaume
  • Patat, Olivier
  • Kuerbitz, Jeffrey
  • Rzucidlo, Susan
  • Sell, Susan S.
  • Gordon, Patricia
  • Schuhmann, S.
  • Reis, André|||0000-0002-6301-6363
  • Halleb, Yosra
  • Stoeva, Radka|||0000-0002-6383-8201
  • Keren, Boris
  • Al Masseri, Zainab|||0000-0002-6202-3721
  • Tumer, Zeynep|||0000-0002-4777-5802
  • Hammer-Hansen, Sophia|||0000-0003-1298-7490
  • Krüger Sølyst, Sofus
  • Steigerwald, Connolly G.
  • Abreu, Nicolas J.|||0000-0002-8288-6268
  • Faust, Helene
  • Müller-Nedebock, Amica
  • Tran Mau-Them, Frederic|||0000-0002-3795-9456
  • Sticht, Heinrich
While mostly de novo truncating variants in SCAF4 were recently identified in 18 individuals with variable neurodevelopmental phenotypes, knowledge on the molecular and clinical spectrum is still limited. We assembled data on 50 novel individuals with SCAF4 variants ascertained via GeneMatcher and personal communication. With detailed evaluation of clinical data, in silico predictions and structural modeling, we further characterized the molecular and clinical spectrum of the autosomal dominant SCAF4-associated neurodevelopmental disorder. The molecular spectrum comprises 25 truncating, eight splice-site and five missense variants. While all other truncating variants were classified as pathogenic/likely pathogenic, significance of one C-terminal truncating variant, one splice-site variant and the missense variants remained unclear. Three missense variants in the CTD-interacting domain of SCAF4 were predicted to destabilize the domain. Twenty-three variants occurred de novo, and variants were inherited in 13 cases. Frequent clinical findings were mild developmental delay with speech impairment, seizures, and skeletal abnormalities such as clubfoot, scoliosis or hip dysplasia. Cognitive abilities ranged from normal IQ to severe intellectual disability (ID), with borderline to mild ID in the majority of individuals. Our study confirms the role of SCAF4 variants in neurodevelopmental disorders and further delineates the associated clinical phenotype.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Anxiety disorder is a common psychopathological comorbidity in patients with SHANK pathogenic variants, description of five new cases

  • Manso-Bazús, Carmen|||0000-0002-7118-1203
  • Spataro, Nino|||0000-0002-2127-2238
  • Plans, Laura
  • Tomàs, Meritxell
  • Casadesús, Mercè
  • Pamias, Montserrat|||0000-0003-1114-5419
  • Ruiz, Anna|||0000-0001-7314-5962
Pathogenic variants in the SHANK family genes have been linked to autism spectrum disorder, as well as to other neuropsychiatric and neurodevelopmental disorders. We aim to characterise the neurodevelopmental, neuropsychiatric and dysmorphic features of five additional patients with SHANK1 and SHANK2 and SHANK3 pathogenic variants to highlight a prevalent neuropsychiatric phenotype common to SHANK family members. Whole exome sequencing was performed in 115 patients (aged 6-18 years) with mild intellectual disability/borderline intellectual functioning and a psychiatric comorbidity. Neurodevelopmental, clinical, psychopathological and dysmorphological features of patients with pathogenic variants in SHANK genes were collected. Intragenic pathogenic variants in SHANK1, SHANK2, and SHANK3 were identified in five patients. All patients presented significant language and motor delay and autism spectrum disorder as the most prevalent psychiatric comorbidity. Generalised anxiety disorder was present in four out of five patients, while one patient presented a non-specific anxiety disorder. This study identifies five new patients with pathogenic variants in the SHANK genes that present generalised anxiety disorder as a common psychopathological comorbidity. Identification of the underlying genetic cause in children and adolescents with mild or borderline intellectual disability may improve their clinical management, allowing a personalized approach, and providing precise genetic counselling to the family.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders

  • Spataro, Nino|||0000-0002-2127-2238
  • Trujillo-Quintero, Juan Pablo|||0000-0001-5901-9388
  • Manso-Bazús, Carmen|||0000-0002-7118-1203
  • Gabau, Elisabeth|||0000-0001-8120-7393
  • Capdevila, Núria|||0000-0003-2080-7381
  • Martinez-Glez, Víctor|||0000-0002-4680-881X
  • Berenguer-Llergo, Antoni|||0000-0002-3742-8161
  • Reyes, Sara
  • Brunet Vega, Anna|||0000-0002-2723-0469
  • Baena Díez, Neus|||0000-0003-0677-240X
  • Guitart, Maria|||0000-0003-2957-7404
  • Ruiz, Anna|||0000-0001-7314-5962
Neurodevelopmental disorders (NDDs) affect 2-5% of the population and approximately 50% of cases are due to genetic factors. Since de novo pathogenic variants account for the majority of cases, a gene panel including 460 dominant and X-linked genes was designed and applied to 398 patients affected by intellectual disability (ID)/global developmental delay (GDD) and/or autism (ASD). Pathogenic variants were identified in 83 different genes showing the high genetic heterogeneity of NDDs. A molecular diagnosis was established in 28.6% of patients after high-depth sequencing and stringent variant filtering. Compared to other available gene panel solutions for NDD molecular diagnosis, our panel has a higher diagnostic yield for both ID/GDD and ASD. As reported previously, a significantly higher diagnostic yield was observed: (i) in patients affected by ID/GDD compared to those affected only by ASD, and (ii) in females despite the higher proportion of males among our patients. No differences in diagnostic rates were found between patients affected by different levels of ID severity. Interestingly, patients harboring pathogenic variants presented different phenotypic features, suggesting that deep phenotypic profiling may help in predicting the presence of a pathogenic variant. Despite the high performance of our panel, whole exome-sequencing (WES) approaches may represent a more robust solution. For this reason, we propose the list of genes included in our customized gene panel and the variant filtering procedure presented here as a first-tier approach for the molecular diagnosis of NDDs in WES studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Case report, Identification of a novel variant p.Gly215Arg in the CHN1 gene causing Moebius syndrome

  • Manso-Bazús, Carmen|||0000-0002-7118-1203
  • Spataro, Nino|||0000-0002-2127-2238
  • Gabau, Elisabeth|||0000-0001-8120-7393
  • Beltrán-Salazar, Viviana P.|||0000-0001-9026-2204
  • Trujillo-Quintero, Juan Pablo|||0000-0001-5901-9388
  • Capdevila, Núria|||0000-0003-2080-7381
  • Brunet Vega, Anna|||0000-0002-2723-0469
  • Baena Díez, Neus|||0000-0003-0677-240X
  • Jeyaprakash, A. Arockia
  • Martinez-Glez, Víctor|||0000-0002-4680-881X
  • Ruiz, Anna|||0000-0001-7314-5962
Background: Moebius Syndrome (MBS) is a rare congenital neurological disorder characterized by paralysis of facial nerves, impairment of ocular abduction and other variable abnormalities. MBS has been attributed to both environmental and genetic factors as potential causes. Until now only two genes, PLXND1 and REV3L have been identified to cause MBS. Results: We present a 9-year-old male clinically diagnosed with MBS, presenting facial palsy, altered ocular mobility, microglossia, dental anomalies and congenital torticollis. Radiologically, he lacks both abducens nerves and shows altered symmetry of both facial and vestibulocochlear nerves. Whole-exome sequence identified a de novo missense variant c.643G